JOSEFA FERREIRO QUINTANA-rekin lankidetzan egindako argitalpenak (8)

2008

  1. Prognostic factors in cancer of unknown primary site

    Clinical and Translational Oncology

2007

  1. Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer [5]

    Annals of Oncology

2005

  1. High-dose interleukin-2 in metastatic renal cell carcinoma [3]

    Journal of Clinical Oncology

2004

  1. Factores pronósticos y predictivos en pacientes con cáncer de origen desconocido tratados con un esquema de quimioterapia con paclitaxel

    Medicina Clinica, Vol. 122, Núm. 6, pp. 216-218

  2. Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme

    Tumori, Vol. 90, Núm. 6, pp. 562-566

2003

  1. A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer

    International Journal of Clinical Pharmacology Research, Vol. 23, Núm. 1, pp. 9-16

  2. Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer [3]

    Journal of the National Cancer Institute

2002

  1. Phase II study of docetaxel/vinorelbine in patients with non-small-cell-lung cancer previously treated with platinum-based chemotherapy

    Clinical Lung Cancer, Vol. 4, Núm. 3, pp. 168-173